|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.00 SAR | +0.58% |
|
-4.14% | -1.91% |
| Capitalization | 11.12B 2.97B 2.5B 2.28B 2.18B 4.04B 269B 4.2B 26.51B 10.52B 130B 10.89B 453B | P/E ratio 2025 * |
15.9x | P/E ratio 2026 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise value | 11.32B 3.02B 2.54B 2.32B 2.21B 4.11B 273B 4.27B 26.97B 10.71B 132B 11.08B 461B | EV / Sales 2025 * |
3.75x | EV / Sales 2026 * | 3.49x |
| Free-Float |
47.98% | Yield 2025 * |
2.52% | Yield 2026 * | 2.77% |
| 1 day | +0.58% | ||
| 1 week | -4.14% | ||
| Current month | -7.33% | ||
| 1 month | -6.21% | ||
| 3 months | -1.56% | ||
| 6 months | -6.84% | ||
| Current year | -1.91% |
| 1 week | 137 |  | 148.3 |
| 1 month | 137 | | 156.8 |
| Current year | 137 | | 156.8 |
| 1 year | 125.6 | | 193 |
| 3 years | 52.9 | | 207 |
| 5 years | 26.3 | | 207 |
| 10 years | 11.8 | | 207 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2014 | |
Samer Hendawi
DFI | Director of Finance/CFO | - | 13/03/2018 |
Khaled Al-Balawi
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Khaled Al-Mana
BRD | Director/Board Member | - | 22/04/2019 |
Sabih Al-Masri
CHM | Chairman | 88 | 01/01/1979 |
| Director/Board Member | - | 22/04/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.58% | -4.14% | -27.60% | +159.81% | 2.97B | |
| -1.01% | +0.14% | -2.80% | +67.20% | 44.97B | |
| +7.23% | +13.28% | +30.34% | +158.17% | 36.57B | |
| +0.11% | +0.11% | -9.55% | +30.29% | 11.88B | |
| -1.76% | +1.86% | -4.05% | +91.90% | 10.05B | |
| -0.84% | +1.73% | +43.73% | +121.70% | 8.5B | |
| +2.69% | +7.00% | +196.89% | +928.85% | 8.62B | |
| -1.21% | +7.31% | +71.26% | +33.63% | 8.19B | |
| +1.26% | +2.09% | +62.23% | -10.40% | 7.8B | |
| -0.51% | +1.92% | +9.24% | +47.26% | 6.68B | |
| Average | +0.65% | +1.84% | +36.97% | +162.84% | 14.62B | |
| Weighted average by Cap. | +1.48% | +3.79% | +27.00% | +137.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.02B 804M 678M 618M 590M 1.1B 72.84B 1.14B 7.19B 2.85B 35.18B 2.95B 123B | 3.22B 860M 725M 661M 631M 1.17B 77.89B 1.22B 7.69B 3.05B 37.61B 3.16B 131B |
| Net income | 699M 186M 157M 143M 137M 254M 16.88B 264M 1.67B 661M 8.15B 685M 28.49B | 734M 196M 165M 150M 144M 266M 17.71B 277M 1.75B 694M 8.55B 718M 29.9B |
| Net Debt | 196M 52.26M 44.04M 40.17M 38.35M 71.18M 4.73B 73.96M 467M 185M 2.29B 192M 7.99B | 123M 32.8M 27.64M 25.21M 24.06M 44.67M 2.97B 46.41M 293M 116M 1.43B 120M 5.01B |
Employees
3,800
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/02/26 | 139.00 ﷼ | +0.58% | 30,120 |
| 11/02/26 | 138.20 ﷼ | -0.22% | 213,454 |
| 10/02/26 | 138.50 ﷼ | -0.36% | 51,525 |
| 09/02/26 | 139.00 ﷼ | -2.11% | 97,103 |
| 08/02/26 | 142.00 ﷼ | -2.07% | 70,628 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
139.00SAR
Average target price
162.00SAR
Spread / Average Target
+16.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1212 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition